The diagnosis is based on clinical suspicion during EGFR-TKI treatment, detection of lung parenchymal infiltration on radiological assessment, and diagnostic exclusion of tumor progression, cardiac diseases, or other pulmonary complications, such as infectious pneumonitis [55,76]. Here, EGFR is linked to heart disorder.